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Abstract
Kinmen Benefit Life medicated wine (KBLMW), a medicated wine with unified formulas proclaimed by the Committee on
Chinese Medicine and Pharmacy (Department of Health, Executive Yuan, Taiwan), was made of 17 kinds of Chinese medicinal
materials soaked in 25% alcohol. KBLMW has been widely used as conventional or complementary medicines for health regimen.
In the present study, Wistar rats were administered once daily via gastric tube with KBLMW, de-alcoholic KBLMW (0% alcohol/
vol) or 25% alcohol at 2.08 mL/kg/day for 12 consecutive weeks, to clarify the role of alcohol in the induction of hepatic disorders
by chronic consumption of KBLMW at the recommended intake amount. At the end of this treatment, the liver fibrosis in rats
receiving 25% alcohol was found, featuring increase in serum levels of alanine transaminase and aspartate aminotransferase, as
well as hepatic hydroxyproline contents. Comparing with the normal group, values of these serum indexes in KBLMW-fed rats
elevated moderately but lower than those of 25% alcohol-fed rats. Also, the stage of liver fibrosis in KBLMW-treated rats was less
advanced than that in 25% alcohol-treated group. In addition, the liver function parameters in rats receiving de-alcoholic KBLMW
were close to those of normal group and liver fibrosis was not observed. The results suggest that alcohol is related to the induction
of hepatic injury by chronic consumption of medicated wine even at the recommended daily intake amount. This finding can be
used as the safety reference guide for clinical medicated wine drinking.
Key words: medicated wine, alcohol, Chinese medicinal materials, liver fibrosis

Introduction
Chinese medicine has been applied to medicine for
centuries and is now being gradually accepted worldwide.
In the West, people tend to take a single herb in therapies
and try to identify the active ingredients and therapeutic
mechanisms, whereas in Chinese medicine it is common
to use mixtures of various medicinal herbs, which contain
a range of pharmacologically active ingredients working
additively/synergistically, to treat patients or to reduce
harmful side effects of some chemical compounds(1,2).
Among them, medicated wine, which is usually made
by soaking the fresh or dried Chinese medicinal materials, in solutions containing more than 20% of alcohol, has
been used as conventional or complementary medicines
for health regimen as well as disease prevention. Actually,
chronic alcohol consumption leads to several metabolic
disorders including hepatic diseases(3), which are initiated
by reactive oxygen species generation and lipid peroxidation as found in liver, leading to cellular damage(4). Thus,
* Author for correspondence. Tel: +886-4-26318652 ext. 3100;
Fax: + 886-4-26338212; E-mail: jtc9009@sunrise.hk. edu.tw

heavy drinkers and alcoholics tend to have liver cell
damage and cirrhosis, and some may eventually develop
hepatocellular carcinoma, which is unfortunately, and very
often, a fatal malignancy without cure(5). Unlike the case
of heavy alcohol abuse, the safety evaluation for chronic
consumption of medicated wine is not yet fully understood.
Kinmen Benefit Life medicated wine (KBLMW),
one kind of the unified formulas of medicated wine
proclaimed by the Committee on Chinese Medicine
and Pharmacy, Department of Health, Executive Yuan,
Taiwan, is made of 17 kinds of Chinese medicinal materials soaked in 25% alcohol (Table 1). The prescription is
commonly used to increase blood circulation to relieve
stasis, strengthening “spleen” as well as supplementing “qi” to reinforce body’s immunological function.
The recommended intake amount of medicated wine for
people is usually 10~20 mL per administration, 2 or 3
times daily. Thus, this formula was used in this study to
evaluate the safety for chronic administration of medicated wine at the recommended daily intake amount through
examination of liver function and histopathology, in an
effort to reveal the role of alcohol and formula in the
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Table 1. The Chinese medicinal materials contained in Kinmen
benefit life medicated wine
Pharmaceutical name

Composition (mg)

Equus Asinus Colla Corii

2.6

Hominis Placenta

5.2

Chinemys Reevesii Gelatinum Plastrum

2.6

Gekko Gecko

5.2

Cervi Nippon Colla Cornu (Gelatin)

2.6

Rubus Chingii Fructus

2.6

Hippocampus Histrix

10.4

Ligustrum Lucidum Fructus

5.2

Polygonatum Sibiricum Rhizoma

5.2

Rehmannia Glutinosa Radix Conquita

5.2

Panax Ginseng Radix

0.5

Cynomorium Songaricum Herba

5.2

Cinnamomum Cassia Cortex

0.5

Citrus Reticulata Pericarpium

1.6

Cervus Pantotrichum Comu

1.0

Lycium Barbarum Fructus

5.2

Angelica Sinensis Radix

5.2

Mixture of Chinese medicinal materials was soaked with 1 mL of
25% alcohol following the principals of Chinese medicated wine
from Committee on Chinese Medicine and Pharmacy.

pathogenesis of alcoholic liver disease.

MATERIALS AND METHODS
I. Materials
KBLMW was made of authentic Chinese medicinal materials of highest qualities soaked in 25% alcohol
following the principals of Chinese medicated wine by
Committee on Chinese Medicine and Pharmacy at Han
Sheng Pharmtech, Inc. (Pingtung City, Pingtung County,
Taiwan) under internationally certified Good Manufacturing Practices guidelines. The experienced botanists
and chemists in the supplier performed macroscopic and
microscopic examinations as well as thin-layer chromatography and high-performance liquid chromatography
to authenticate the plants, plant parts used, and processed
raw herbs. The reference specimens were deposited at
the herbarium of supplier. De-alcoholic KBLMW (0%
alcohol/vol), the product including Chinese medicinal
materials of KBLMW but not alcohol, was obtained from
KBLMW dealcoholized at Han Sheng Pharmtech, Inc. by
vacuum distillation. Standard rat chow was from Purina
Mills, LLC (St. Louis, Missouri, USA). Diagnostic kit
for the determination of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were
purchased from Roche Diagnostics Corp. (Indianapolis,

Indiana, USA). Chloramines T solution was from SigmaAldrich, Inc. (St. Louis, Missouri, USA). The kit for
protein assay was from Bio-Rad Laboratories (CA, USA).
All chemicals were of analytical grade.
II. Animals and Protocol
Male Wistar rats aged 8 weeks were obtained from
the Animal Center of the Medical College, National
Cheng Kung University. They were kept in a temperature-controlled room (25 ± 1°C) and on a 12:12 light-dark
cycle (light on at 06:00 AM). After normal feeding for
a week, these rats were randomly assigned into four
groups: (1) normal group (n = 10), (2) KBLMW-fed group
(n = 10), (3) de-alcoholic KBLMW-fed group (n = 10), and
(4) 25% alcohol-fed group (n = 10). A metabolism coefficient of 6.25 was employed to convert the recommended
daily intake amount of KBLMW for people (20 mL/day)
into rats, assuming that average body weight of an adult
is 60 kg(5). All animals were administered once daily via
gastric tube. KBLMW-fed group was given KBLMW at
2.08 mL/kg/day, de-alcoholic KBLMW-fed group was fed
with de-alcoholic KBLMW prepared in distilled water
at 2.08 mL/kg/day, rats given 25% alcohol at 2.08 mL/
kg/day was the alcoholic liver disease model group, and
the normal control group were given an equal volume of
distilled water at 2.08 mL/kg/day. All animal procedures
were performed according to the Guide for the Care and
Use of Laboratory Animals of the National Institutes of
Health, as well as the guidelines of the Animal Welfare
Act. At the end of 12-week treatment, all the rats were
anaesthetized and sacrificed. Blood sample and liver
tissue specimens were collected. Plasma was separated
by centrifugation at 4°C and kept at -20°C for assay.
Liver tissue was fixed for histopathology.
III. Serum ALT and AST Assay
ALT and AST were evaluated in samples of serum
obtained at the end of treatment. The activity was determined spectrophometrically with an automatic analyzer
(HG-310, HITACHI, Japan) using commercially available
kits according to instructions.
III. Collagen Measurement by Hydroxyproline Determination in Liver Tissues
Hydroxyproline assays were performed as previously
described with slight modification(6). Liver tissue (0.3 g)
was homogenized in 6 N HCl and hydrolyzed at 110°C for
18 hr. Aliquots (25 μL) were dried at 60°C. The sediment
was dissolved in 1.2 mL of 50% isopropanol and incubated
with 200 mL of 0.56% chloramines T solution in acetate
citrate buffer (pH 6.0). After incubation for 10 min at room
temperature, 1 mL of Ehrlich’s reagent was added and the
mixture was incubated at 50°C for 90 min. After cooling, the absorbance was measured at 558 nm (BECMAN,
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DU530, USA). Hepatic protein concentration was determined by the BioRad protein dye binding assay. The
amount of hydroxyproline was expressed as μg/mg protein.

Liver specimens were preserved in 4% buffered
paraformaldehyde, dehydrated in a graded alcohol series,
embedded in paraffin and cut into 5 μm thick sections
which were placed on plain glass slides. The paraffinembedded tissue was sectioned for staining with hematoxylin-eosin and Masson trichome. Fibrosis was graded
according to the previous method as follows (7): grade 0
= normal liver, grade 1 = increase of collagen without
formation of septa, grade 2 = formation of incomplete
septa from portal tract to central vein (septa that do not
interconnect with each other), grade 3 = complete but
thin septa interconnecting with each other, so as to divide
the parenchyma into separate fragments, and grade 4 = as
grade 3, except with thick septa (complete cirrhosis). To
avoid sampling error, all biopsies were obtained from the
same liver lobe and these semi-quantitative grading were
performed by the observer without knowledge of sample
treatment under a light microscope.

ed and ran around the cage. After that they could not
walk, and at last fell into a sound sleep, while there was
minor syndromes in KBLMW-fed groups. Actually, the
behavior in rats fed with 25% alcohol did not show in dealcoholic KBLMW-fed group. It seems that the chance
to produce acute toxicity is very high in individual even
taking alcoholic solution at micro- to moderate amount,
but Chinese medicinal materials in KBLMW posses the
ability to alleviate the toxicity.
As experiment proceeded to 10 weeks, spoor time
changed from 1~2 hr to about 5 hr in 25% alcohol-fed
rat. Similar to the previous study(8), the body weight
gain was significantly lower in the rats fed 25% alcohol
at 10th week than the other groups for the same period.
Furthermore, the body weight of 25% alcohol-fed rats fell
obviously and maintained cachexia at the 12th week as
compared to that of KBLMW-fed group. However, these
metabolic derangements did not appear in rats receiving 12-week of de-alcoholic KBLMW administration.
Although the concentration of alcohol is the same, the
chance for chronic toxicity induction in 25% alcohol-fed
rats is higher than that in KBLMW. Thus, the potential
clinical therapeutic value for individuals with alcoholic
liver injury warrants further attention.

V. Statistical Analysis

II. Serum Levels of ALT and AST

Data are expressed as the mean ± SEM for each
group of animals in Tables. Statistical differences among
groups were determined by using two-way repeatedmeasures ANOVA. The Dunnett range post-hoc comparisons were used to determine the source of significant
differences where appropriate. A P-value < 0.05 was
considered statistically significant.

Serum levels of ALT and AST are indexes to describe
liver functions. Most of ALT is present in the cytoplasm of
liver cell and will be discharged into blood when degeneration, hyperpermeability and necrosis of liver cells occur.
The increase of ALT level in serum thus reflects the degree
of liver cell injury(9). Indeed, it has been shown that the
activities of AST and ALT were significantly raised in
rats fed with alcohol for 10 week(8). As shown in Table
2, rats receiving a 12-week of 25% alcohol administration
has a marked increase in serum levels of ALT and AST,
as compared to those in normal group. After 12 weeks of
KBLMW consumption, all the indexes in rats were elevated as compared to those of normal group, but the values
were still lower than those of 25% alcohol-fed rats relatively. It was noteworthy that each index in de-alcoholic

IV. Pathological Evaluation

RESULTS and Discussion
I. Rat Condition
During the first week of the experimental period,
when the rats were given 25% alcohol, they became excit-

Table 2. Changes in the level of serum ALT, AST and hepatic hydroxyproline in rats receiving a 12-week treatment with Kinmen Benefit
Life medicated wine (KBLMW)
Group

ALT (U/L)
Before

Normal

AST (U/L)
After

d

48.3 ± 4.7

d

d

50.9 ± 6.4

158.7 ± 7.8

159.2 ± 9.7

9.9 ± 3.7d

d

9.7 ± 3.1

159.1 ± 9.2

512.3 ± 16.7

9.8 ± 3.4

27.9 ± 4.2b

KBLMW

49.4 ± 5.6d

192.8 ± 10.1b,c

157.9 ± 7.4d

329.4 ± 14.3b,c

9.8 ± 2.6d

16.1 ± 3.5a, c

48.7 ± 4.5

51.6 ± 7.2

d

158.2 ± 8.3

b

After
d

276.3 ± 15.3
d

d

Before
d

49.2 ± 6.1

d

b

Hydroxyproline (μg/mg protein)
After

25% alcohol
De-alcoholic KBLMW

d

Before

d

161.5 ± 10.2

d

9.9 ± 2.8

10.3 ± 2.9d

All animals were administered with the indicated prescription at 2.08 mL/kg/day once daily via gastric tube for 12 consecutive weeks.
Values (mean ± SEM) were obtained for each group of 10 animals. Rats received distilled water treatment as the same manner was taken
as normal control. a P < 0.05 and bP < 0.01 represents the level of significance compared to the values of normal control before treatment,
respectively. cP < 0.05 and d P < 0.01 compared to the values of 25% alcohol-treated rats at the end of treatment, respectively.
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KBLMW-fed group was the same as that in normal group,
indicating the Chinese medicine have hepatoprotective
activities against alcoholic toxicity.
II. Hydroxyproline Content in Liver Tissues
The excessive accumulation of extracellular matrix
proteins, including collagen, occurs in chronic liver
diseases (10). Hydroxyproline, a major component of the
protein collagen, is produced by hydroxylation of proline,
and helps provide stability to the triple-helical structure
of collagen by forming hydrogen bonds (11). The alteration of hydroxyproline levels in the liver is considered as
an index of collagen metabolism and provides valuable
information about the biochemical and pathologic events
of hepatic fibrosis (12). Therefore the hydroxyproline
assay was used as a method for collagen measure.
In this study, we observed that liver hydroxyproline
level in 25% alcohol-fed rats was much higher than those
of the normal controls at the end of a 12-week treatment
(Table 2). Liver hydroxyproline level in KBLMW-fed
group was also higher than that of normal group, but the
value was significantly lower than that of 25% alcohol-fed
rats (Table 2). Interestingly, the liver hydroxyproline level
of rats receiving a 12-week treatment with de-alcoholic
KBLMW has no significant difference from the control
group (Table 2). Thus, Chinese medicinal materials in
KBLMW possibly displayed their hepatoprotective effects
through their effects against hydroxyproline formation.
III. Histological Changes under an Optical Microscope
When the liver is damaged, it can initiate regenerative actions (13), thus increasing the weight of liver. If it
is heavily damaged, however, liver fibrosis and cirrhosis
can result in liver atrophy(14). Therefore, the change in
weight of liver cannot predict directly the pathological processes in chronic liver injuries. Histopathologic
examination was thus performed to prove that the fibrosis was caused by alcohol but not the Chinese medicinal
materials of KBLMW.
At the end of treatment, the liver of control rats had

no appreciable alterations (Figure 1A, Table 3). In 25%
alcohol-fed rats group, the margin of liver was uneven
with more fibrous tissues formed and extended into the
hepatic lobules to separate them incompletely and a large
amount of inflammatory cells infiltrated in the intralobular and the interlobular regions. The liver structure
was disordered with some displacement of central veins,
and there were more necrotic and degenerated liver cells
as compared with the control (Figure 1B, Table 3). In
KBLMW-treated groups, the pathological changes of
liver was rather milder, showing less fibrous tissue proliferation and inflammatory cell infiltration in the interlobular space, where only micro- and moderate steatosis
were found (Figure 1C, Table 3). As expected, steatosis
could nearly not be seen in de-alcoholic KBLMW -treated groups (Figure 1D, Table 3).
According to traditional Chinese medicine theory,
“alcohol is pungent and hot”. It has been documented
that dampness, heat and gore are the major pathogenesis
of alcoholic liver disease. In regard to theories, most
components in medicated wine can invigorate blood
circulation, remove blood stasis, cool the blood, treat
carbuncles and tranquilize the disturbed mind by nourishing the blood. It could be considered that Chinese
medicinal materials with the unique function in clearing
dampness and heat of liver to eliminate the gore of the
blood might have hepatoprotective property. Actually,
drugs in KBLMW can also expel pathogenic factors from
the exterior to reduce fever, sooth the depressed liver
and invigorate the spleen-yang; thus, it is reasonable that
hepatic injury was not observed in de-alcoholic KBLMW
groups at the end of 12-week treatment. The results definitely demonstrate that even at the recommended daily
intake amount, alcohol must be of pathophysiological
importance in the process of hepatic injury in person
with the habit of drinking medicated wine.
Actually, alcohol is essential for the production of
Chinese medicinal materials since it is the best solvent to
extract and concentrate the active ingredients, to preservative the active constituents of most Chinese medicinal
materials. Therefore, not only the recommended daily
intake of medicated wine, but also the content of alcohol

Table 3. Pathological observation of liver condition in rats receiving a 12-week treatment with Kinmen Benefit Life medicated wine
(KBLMW)
Group

Score of hepatic fibrosis

Average

0

1

2

3

4

Normal control

10

0

0

0

0

0d

25% alcohol

0

0

0

3

7

3.7 ± 0.5b

KBLMW

0

1

6

3

0

2.2 ± 0.3a,c

De-alcoholic KBLMW

10

0

0

0

0

0d

All animals were administered with the indicated prescription at 2.08 mL/kg/day once daily via gastric tube for 12 consecutive weeks.
Values (mean ± SEM) were obtained for each group of 10 animals. Rats received distilled water treatment as the same manner was taken as
normal control. a P < 0.05 and bP < 0.01 represents the level of significance compared to the values of normal control, respectively. cP < 0.05
and d P < 0.01 compared to the values of 25% alcohol-treated rats, respectively.
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(A)

(B)

(C)

(D)

Figure 1. Analysis of liver pathology of each group under light microscope (original magnif ication, ×200). All animals were
administered with the indicated prescription at 2.08 mL/kg/day once daily via gastric tube for 12 consecutive weeks. (A) normal control
group; (B) 25% alcohol-fed group; (C) KBLMW-fed group; (D) de-alcoholic KBLMW-fed group.

in the preparation of medicine, needs to be modified in
order to preserve the benefit in health regimen and to avoid
liver injury as possible. In addition, the real mechanism of
alcohol-induced hepatic cells injury is still not completely
clear. Some researchers found that alcohol could activate
lipid peroxidation, leading to liver injury(4,8). Among the
components of KBLMW, Lycium barbarum fructus is well
known for nourishing the liver, and in turn, improving the
eyesight(15). It has also been reported that ginsenoside
Rb1, one of the active compounds of Panax ginseng, has
hepatoprotective effect on tert-butyl hydroperoxideinduced liver injury(16). Whether the cytoprotective effects
of Chinese medicinal materials in KBLMW mainly attributable to antioxidant and free radical scavenging properties remained to be clarified.
Although Chinese medicinal materials has been
employed in the treatment of liver diseases(17,18), hepatic
impairment resulting from the use of conventional drugs is
widely acknowledged(19). In fact, there is little awareness

of the potential hepatotoxicity of herbal preparations and
other botanicals, many of which are believed to be harmless and are commonly used for self-medication without
supervision. Research is needed to further demonstrate
the safety and efficacy of the medicated wine.

Conclusions
The obtained data showed that alcohol is related to
the induction of hepatic injury due to chronic consumption of medicated wine even at the recommended daily
intake dose. It can be considered as the reference of safe
strategy for the application of medicated wine in clinic.

Acknowledgements
The present study was supported by a grant (CCMP

471
Journal of Food and Drug Analysis, Vol. 15, No. 4, 2007

95-CP-010) from the Committee on Chinese Medicine
and Pharmacy, Department of Health, Executive Yuan,
Taiwan (ROC).

References
1. Gurib-Fakim, A. 2006. Medicinal plants: traditions
of yesterday and drugs of tomorrow. Mol. Aspects
Med. 27: 1-93.
2. Wang, M., Lamers, R. J., Korthout, H. A., van Nesselrooij, J. H., Witkamp, R. F., van der Heijden, R.,
Voshol, P. J., Havekes, L. M., Verpoorte, R. and van
der Greef, J. 2005. Metabolomics in the context of
systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytother Res.
19: 173-182.
3. Lieber, C. S. 2000. Hepatic, metabolic, and nutritional disorders of alcoholism: from pathogenesis to
therapy. Crit. Rev. Clin. Lab. Sci. 37: 551-584.
4. Albano, E. 2006. Alcohol, oxidative stress and free
radical damage. Proc. Nutr. Soc. 65: 278-290.
5. Hodge, H. C., Downs, W. L., Panner, B. S., Smith,
D. W. and Maynard, E. A. 1967. Oral toxicity and
metabolism of diuron (N-(3,4-dichlorophenyl)-N’,N’dimethylurea) in rats and dogs. Food Cosmet. Toxicol. 5: 513-531.
6. Jamall, I. S., Finelli, V. N. and Que Hee, S. S. 1981.
A simple method to determine nanogram levels of
4-hydroxyproline in biological tissues. Anal. Biochem.112: 70-75.
7. Ruwar t, M. J., Wilkinson, K. F., Rush, B. D.,
Vidmar, T. J., Peters, K. M., Henley, K. S., Appelman, H. D., Kim, K. Y., Schuppan, D. and Hahn, E.
G. 1989. The integrated value of serum procollagen
III peptide over time predicts hepatic hydroxyproline
content and stainable collagen in a model of dietary
cirrhosis in the rat. Hepatology 10: 801-806.
8. Kwon, H. J., Kim, Y. Y. and Choung, S. Y. 2005.
Amelioration effects of traditional Chinese medicine
on alcohol-induced fatty liver. World J. Gastroenterol. 11: 5512-5516.

9. Burke, M. D. 1974. Hepatic function tests. Geriatrics
29: 75-80.
10. Schuppan, D. 1990. Structure of the extracellular
matrix in normal and fibrotic liver: collagens and
glycoproteins. Semin. Liver Dis.10: 1-10.
11. Bansal, M. and Ananthanarayanan, V. S. 1988. The
role of hydroxyproline in collagen folding: conformational energy calculations on oligopeptides containing proline and hydroxyproline. Biopolymers 27:
299-312.
12. George, J. and Chandrakasan, G. 2000. Biochemical abnormalities during the progression of hepatic
fibrosis induced by dimethylnitrosamine. Clin. Biochem. 33: 563-570.
13. Yamada, Y. and Fausto, N. 1998. Deficient liver
regeneration after carbon tetrachloride injury in
mice lacking type 1 but not type 2 tumor necrosis
factor receptor. Am. J. Pathol. 152: 1577-1589.
14. Yu, M. S., Ho, Y. S., So, K. F., Yuen, W. H. and
Chang, R. C. 2006. Cytoprotective effects of Lycium
barbarum against reducing stress on endoplasmic
reticulum. Int. J. Mol. Med. 17: 1157-1161.
15. Lee, H. U., Bae, E. A., Han, M. J., Kim, N. J. and
Kim, D. H. 2005. Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury. Liver Int. 25: 1069-1073.
16. Perez Tamayo, R. 1983. Is cirrhosis of the liver
experimentally produced by CCl4 and adequate
model of human cirrhosis? Hepatology 3: 112-120.
17. Dhiman, R. K. and Chawla, Y. K. 2005. Herbal medicines for liver diseases. Dig. Dis. Sci. 50: 1807-1812.
18. Wang, R., Kong, J., Wang, D., Lien, L. L. and Lien,
E. J. 2007. A survey of Chinese herbal ingredients
with liver protection activities. Chin. Med. 2: 5
19. Stickel, F., Egerer, G. and Seitz, H. K. 2000. Hepatotoxicity of botanicals. Public Health Nutr. 3: 113124.

